Page last updated: 2024-11-01

ns 1619 and Ischemia

ns 1619 has been researched along with Ischemia in 1 studies

NS 1619: structure given in first source
NS 1619 : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one in which the hydrogens at positions 1 and 5 are replaced are replaced by 2-hydroxy-5-(trifluoromethyl)phenyl and trifluoromethyl groups, respectively. It is an opener/activator of the large-conductance calcium-activated potassium channel (Bkca).

Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wrzosek, A1

Other Studies

1 other study available for ns 1619 and Ischemia

ArticleYear
The potassium channel opener NS1619 modulates calcium homeostasis in muscle cells by inhibiting SERCA.
    Cell calcium, 2014, Volume: 56, Issue:1

    Topics: Animals; Benzimidazoles; Calcium; Cell Line; Guinea Pigs; Homeostasis; Ischemia; Mice; Muscle Contra

2014